Glazer Capital, Llc
Source: SEC Form 13F · as of Mar 2026Glazer Capital, Llc holds 10 biotech & pharma companies tracked by BioSniper, totaling $652K in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$652K
| Company | Shares | Value |
|---|---|---|
| FOLDAMICUS THERAPEUTICS, INC. | 12,722,749 | $184K |
| ACLXArcellx, Inc. | 1,511,570 | $173K |
| TERNTerns Pharmaceuticals, Inc. | 2,295,498 | $121K |
| DAWNDay One Biopharmaceuticals, Inc. | 4,683,687 | $100K |
| APLSApellis Pharmaceuticals, Inc. | 1,295,828 | $52K |
| CNTACentessa Pharmaceuticals plc | 325,001 | $13K |
| IPEXInflection Point Acquisition Corp. V | 626,074 | $7K |
| CCXIChemoCentryx, Inc. | 192,432 | $2K |
| CMIIUColumbus Circle Capital Corp II Unit | 1,444 | $14 |
| RNAAtrium Therapeutics Inc. | 2,634 | $0 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.